Daewoong Pharmaceutical and Affyxell Therapeutics said they would cooperate with Seoul National University Hospital (SNUH) in developing regenerative medicine and advanced biopharmaceuticals.The three have signed a memorandum of understanding to establish a regenerative medical infrastructure and co
Bridge Biotherapeutics said that it signed an exclusive option-to-license agreement for Cellion BioMed’s ion channel modulator to develop a novel therapy for multiple fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).The substance, named BBT-301, is an innovative drug candidate that h
The government will start providing Covid-19 vaccines to children aged 5-11 soon, starting with high-risk groups due to weakened immunity, Korea Disease Control and Prevention Agency (KDCA) Commissioner Jeong Eun-kyeong said Monday.Jeong said the agency is preparing an inoculation plan for 5- to 11-
The 12th Global Healthcare and Medical Tourism Conference (Medical Korea 2022) will open on Thursday, organized by the Korea Health Industry Development Institute (KHIDI) and hosted by the Ministry of Health and Welfare.Medical Korea 2022 comprises academic conferences, briefing sessions, seminars,
Daewoong Pharmaceutical’s U.S. partner Evolus said Monday that their botulinum toxin product Jeuveau (Nabota in Korea) showed immense sales growth last year, expecting the pace would continue this year.According to Evolus, the sales of Jeuveau in the U.S. reached $99.7 million last year, up 76 perce
Bayer, long a household word in cardiovascular diseases and women's health, is distinguishing itself in new blockbuster candidates and novel platforms while adding to its traditional strength.For instance, the global pharmaceutical giant is undergoing crucial changes by replacing its current blockbu
Hanmi Pharmaceutical said that it has started marketing SynoJoynt, an osteoarthritis injection treatment, with Arthrex, a global medical device company, in the U.S.The treatment, also known as Hyalrheuma in Korea, is a high-molecular-weight hyaluronic acid product produced by Hanmi using its advance
The government decided to push back the business curfew on cafes, restaurants, and other multiuse facilities by an hour to 11 p.m. from Saturday.The eased distancing rules follow the government's decision to temporarily halt the vaccine mandate applied to multiuse facilities and gatherings from Tues
A Severance Hospital team has confirmed that BRCA (Breast Cancer) gene-mutated ovarian cancer patients who took poly ADP ribose polymerase (PARP) inhibitors experience reduced therapeutic efficacy when the disease recurs.An increasing number of patients receive maintenance treatment using PARP inhib
Crystal Bioscience (CBS), a subsidiary of Crystal Genomics specializing in new technology project financing, said Friday it has become the first Korean company to list a special purpose acquisition company (SPAC) on the NASDAQ market.SPAC is a company established exclusively for acquiring unlisted c
Genome and Company said it has entered a clinical collaboration agreement with MSD to develop biliary tract cancer treatment using a combination therapy of GEN-001 and Keytruda.Under the clinical trial collaboration and supply agreement, Genome and Company will conduct a phase 2 clinical trial to ev
Prime Minister Kim Boo-kyum tested positive for Covid-19 on Thursday, making him the highest-ranking government official to test positive for the virus.According to Kim’s office, a polymerase chain reaction (PCR) test on Kim came back positive, adding that he will receive at-home treatment for seven
As the nation confirms more than 200,000 Covid-19 infections per day, Myongji Hospital has opened a rapid polymerase chain reaction (PCR) test center.According to the hospital, the test center, which started operation on Wednesday, will be open all year round from 8:30 a.m. to 10:00 p.m. from Monday
GC said it has applied for product approval for Maralixibat, an Alagille syndrome (ALGS) treatment, to the Food and Drug Safety Ministry.ALGS is a rare genetic disease in children in which the hepatic biliary tract decreases and bile stagnates, and the only available treatment is currently liver tra
A research team at St. Mary's Seoul Hospital has confirmed that an existing model that can predict nonfatal toxicities and survival in cancer patients has the same efficacy on elderly acute myeloid leukemia (AML) patients.AML is a geriatric hematologic cancer with an average age of onset between 65
GI Innovation said it has entered into a partnership with GI Cell and Yonsei University Health System (YUHS) to establish a cell therapy center for advanced biopharmaceuticals.Under the accord, GI Innovation and GI Cell will increase the production capability of advanced biopharmaceuticals with YUHS
Korea's daily Covid-19 cases surpassed 200,000 for the first time on Wednesday as the highly transmissible Omicron variant continues to spread across the nation.The surge in cases comes after the government suspended the vaccine mandate to ease the workload on medical workers and health officials.Un
Alvogen Korea's obesity treatment drug Qsymia (ingredient: phentermine/topiramate) posted more than 26 billion won ($21.5 million) in sales last year to become the only product to maintain growth among approved obesity drugs in Korea.According to IQVIA, a drug market research company, Qsymia recorde
A National Cancer Center research team has confirmed that secondary tumor reduction surgery can improve survival in recurrent ovarian cancer.There have been various opinions about the therapeutic effect of surgery in the treatment strategy for recurrent ovarian cancer, including targeted therapy, im
Organon Korea said Wednesday that the company would do its best to address unmet needs for women's health during their entire lifespans, such as contraception, infertility, pregnancy and childbirth, and menopause."There is a relatively high unmet need in diseases related to women's entire life cycle